Published in J Clin Microbiol on July 01, 2006
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Reemergence of antibiotic-resistant Staphylococcus aureus in the genomics era. J Clin Invest (2009) 3.24
Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg Infect Dis (2006) 2.25
Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California. PLoS One (2013) 1.37
A population-based study of the epidemiology and clinical features of methicillin-resistant Staphylococcus aureus infection in Pennsylvania, 2001-2010. Epidemiol Infect (2013) 1.11
Variability in SCCmecN1 spreading among injection drug users in Zurich, Switzerland. BMC Microbiol (2007) 1.08
Novel anti-infective compounds from marine bacteria. Mar Drugs (2010) 1.08
Epidemiological characteristics of methicillin-resistant Staphylococcus aureus isolates from children with eczematous atopic dermatitis lesions. J Clin Microbiol (2008) 1.04
Methicillin-resistant Staphylococcus aureus nasal carriage among injection drug users: six years later. J Clin Microbiol (2007) 1.00
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates. Antimicrob Agents Chemother (2009) 0.98
USA300 Methicillin-Resistant Staphylococcus aureus, United States, 2000-2013. Emerg Infect Dis (2015) 0.91
Severe necrotizing fasciitis in a human immunodeficiency virus-positive patient caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2008) 0.89
Humans and cattle: a review of bovine zoonoses. Vector Borne Zoonotic Dis (2013) 0.84
A comparative analysis of community acquired and hospital acquired methicillin resistant Staphylococcus aureus. J Clin Diagn Res (2013) 0.84
Potential Antibacterial Targets in Bacterial Central Metabolism. Int J Adv Life Sci (2012) 0.82
Evaluation of Multidrug Resistant Staphylococcus aureus and their Association with Biofilm Production in a Tertiary Care Hospital, Tripura, Northeast India. J Clin Diagn Res (2015) 0.80
Ceftaroline fosamil and treatment of acute bacterial skin and skin structure infections: CAPTURE study experience. J Chemother (2013) 0.79
A case of community-associated methicillin-resistant Staphylococcus aureus infections in a community hospital. J Rural Med (2010) 0.79
Methicillin-Resistant Staphylococcus aureus Recovered from Healthcare- and Community-Associated Infections in Egypt. Int J Bacteriol (2016) 0.75
Molecular and phenotypic characterization of methicillin-resistant Staphylococcus aureus isolates from a tertiary hospital in the Philippines. Trop Med Health (2016) 0.75
Outcome of Decolonization Therapy in a Hospital in Southern Puerto Rico. P R Health Sci J (2015) 0.75
Identifying conditions for elimination and epidemic potential of methicillin-resistant Staphylococcus aureus in nursing homes. Antimicrob Resist Infect Control (2016) 0.75
SmaI restriction site-based multiplex PCR for typing of hospital- and community-acquired Staphylococcus aureus. J Clin Microbiol (2011) 0.75
Staphylococcus aureus infections in children in an Iranian referral pediatric hospital. J Prev Med Hyg (2013) 0.75
Methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium active dimeric isobutyrylphloroglucinol from Ivesia gordonii. Nat Prod Commun (2014) 0.75
Fulminant necrotising fasciitis by community-acquired methicillin-resistant Staphylococcus aureus. BMJ Case Rep (2015) 0.75
Evidence based approach to the treatment of community-associated methicillin-resistant Staphylococcus aureus. Infect Drug Resist (2009) 0.75
Clinical outcomes and treatment approach for community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in Israel. Eur J Clin Microbiol Infect Dis (2016) 0.75
Telavancin: a novel semisynthetic lipoglycopeptide agent to counter the challenge of resistant Gram-positive pathogens. Ther Adv Infect Dis (2017) 0.75
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05
Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA (2003) 12.04
Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus — Minnesota and North Dakota, 1997-1999. MMWR Morb Mortal Wkly Rep (1999) 6.57
Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis (2001) 5.07
Methicillin-resistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations. N Engl J Med (1968) 4.38
The major medical complications of heroin addiction. Ann Intern Med (1967) 4.16
Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep (2003) 4.14
Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med (1982) 3.56
Population-based community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. Clin Infect Dis (2002) 3.53
Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003. MMWR Morb Mortal Wkly Rep (2003) 3.48
Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2003) 3.33
Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis (2003) 2.99
Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA (2001) 2.93
High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis (2000) 2.71
An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. JAMA (1997) 2.52
An outbreak of community-onset methicillin-resistant Staphylococcus aureus skin infections in southwestern Alaska. Infect Control Hosp Epidemiol (2003) 2.31
Soft tissue infections among injection drug users--San Francisco, California, 1996-2000. MMWR Morb Mortal Wkly Rep (2001) 1.86
Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect (1998) 1.72
Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure. Antimicrob Agents Chemother (2005) 1.65
Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics (2004) 1.52
Bacteriology of skin and soft-tissue infections: comparison of infections in intravenous drug users and individuals with no history of intravenous drug use. Clin Infect Dis (1995) 1.30
Soft tissue abscesses associated with parenteral drug abuse: presentation, microbiology, and treatment. Am Surg (1995) 1.21
Clonal characterization of Staphylococcus aureus by multilocus restriction fragment typing, a rapid screening approach for molecular epidemiology. J Clin Microbiol (2003) 1.19
Abscesses secondary to parenteral abuse of drugs. A study of demographic and bacteriological characteristics. J Bone Joint Surg Am (1994) 0.98
Amphotericin B: time for a new "gold standard". Clin Infect Dis (2003) 4.01
Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood (2012) 1.68
Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Res (2002) 1.47
Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend (2007) 1.36
Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. J Acquir Immune Defic Syndr (2004) 1.34
Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction (2007) 1.34
Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol (2003) 1.19
Approval of syringe exchange programs in California: results from a local approach to HIV prevention. Am J Public Health (2007) 1.14
Oral serum-derived bovine immunoglobulin improves duodenal immune reconstitution and absorption function in patients with HIV enteropathy. AIDS (2013) 1.14
Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis (2012) 1.11
Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California. Infect Control Hosp Epidemiol (2005) 1.11
Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J Clin Microbiol (2012) 1.07
Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis (2012) 1.03
Epidemiologic surveillance of Clostridium difficile diarrhea in a freestanding pediatric hospital and a pediatric hospital at a university medical center. Diagn Microbiol Infect Dis (2006) 0.96
Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles. Antimicrob Agents Chemother (2011) 0.94
Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. J Antimicrob Chemother (2003) 0.94
Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing. Ann Pharmacother (2005) 0.93
Secondary syringe exchange among users of 23 California syringe exchange programs. Subst Use Misuse (2006) 0.92
Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis. Clin Infect Dis (2011) 0.91
Strategies to reduce HIV risk behavior in HIV primary care clinics: brief provider messages and specialist intervention. AIDS Behav (2007) 0.89
Treatments for hepatitis B. Clin Infect Dis (2004) 0.88
Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin. Pharmacotherapy (2006) 0.86
Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol (2008) 0.86
Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis (2002) 0.85
Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes. J Subst Abuse Treat (2007) 0.85
Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis. Ann Pharmacother (2005) 0.85
Hepatic mucormycosis with abscess formation. Diagn Microbiol Infect Dis (2012) 0.85
Serum (1->3)-β-D-glucan measurement in coccidioidomycosis. J Clin Microbiol (2012) 0.83
Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital. Diagn Microbiol Infect Dis (2005) 0.83
Isolation of non-toxigenic strains of Clostridium difficile from cases of diarrhea among patients hospitalized in hematology/oncology ward. Pol J Microbiol (2004) 0.83
Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis (2008) 0.83
The continuing saga of MRSA. J Infect Dis (2008) 0.82
HIV risks and seroprevalence among Mexican American injection drug users in California. AIDS Behav (2011) 0.79
Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998. Clin Infect Dis (2005) 0.78
Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection. Med Mycol (2012) 0.77
Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients. Pediatr Nephrol (2008) 0.77
Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest (2013) 0.75
Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75
Cutaneous manifestations of infection in returning travelers. Curr Infect Dis Rep (2014) 0.75
Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis. Neurology (2013) 0.75
Unsuccessful Suicide Attempt With Tiapride. Ther Drug Monit (2017) 0.75
Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients. Clin Pharmacokinet (2012) 0.75